EU Agency Backs Zeltia Group Drug for Ovarian Cancer
Published: Sep 25, 2009
Reuters -- Advisors to European regulators recommended Zeltia's Yondelis drug for use in the treatment of ovarian cancer, sending shares in the Spanish pharmaceutical firm sharply higher.